Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;74:1290-1302

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowler, M. B.
Right arrow Articles by Bristow, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, M. B.
Right arrow Articles by Bristow, M. R.

Circulation, Vol 74, 1290-1302, Copyright © 1986 by American Heart Association


ARTICLES

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

MB Fowler, JA Laser, GL Hopkins, W Minobe and MR Bristow

We developed methods for identifying beta-adrenergic receptors in human right ventricular endomyocardial biopsy tissue with the radioligand (- )[125I]iodocyanopindolol (ICYP). Specific ICYP binding in a crude, high- yield membrane preparation derived from endomyocardial biopsy tissue was high (specificity greater than 90%), of high affinity (KD around 20 pM), saturable and stereospecific for the (-) vs the (+) isomer of isoproterenol. Subjects with mild-moderate and severe biventricular dysfunction had respective decreases in beta-adrenergic receptor density of 38.2% and 57.7% when normalization methods were averaged, with no significant differences in ICYP dissociation constant. A subgroup of subjects was subdivided by left ventricular ejection fraction (LVEF) into those with mild cardiac dysfunction (LVEF less than 0.50 greater than 0.40) and severe heart failure (LVEF less than 0.20) and given graded sequential infusions of dobutamine and calcium gluconate. Those with severe cardiac dysfunction had marked impairment of the dobutamine dP/dt and stroke work index response, whereas these responses to calcium did not differ in the two groups. These data indicate that in the intact human heart endomyocardial biopsy may be used for direct analysis of beta-adrenergic receptors, heart failure- associated myocardial beta-adrenergic down-regulation begins with mild- moderate ventricular dysfunction, reduction in myocardial beta-receptor density is related to degree of heart failure, and beta-receptor down- regulation is associated with pharmacologically specific impairment of the beta-agonist-mediated contractile response.


This article has been cited by other articles:


Home page
JNMHome page
T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki
Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy
J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Krishnamurthy, V. Subramanian, M. Singh, and K. Singh
{beta}1 Integrins Modulate {beta}-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis and Myocardial Remodeling
Hypertension, April 1, 2007; 49(4): 865 - 872.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Otasevic, Z B Popovic, J D Vasiljevic, L Pratali, A Vlahovic-Stipac, S D Boskovic, N Tasic, and A N Neskovic
Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up
Heart, September 1, 2006; 92(9): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Senzaki, S. Masutani, H. Ishido, M. Taketazu, T. Kobayashi, N. Sasaki, H. Asano, T. Katogi, S. Kyo, and Y. Yokote
Cardiac Rest and Reserve Function in Patients With Fontan Circulation
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2528 - 2535.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, S. E. Schiza, H. E. Mavrakis, N. K. Klapsinos, and P. E. Vardas
Acute Electrophysiologic Effects of Inhaled Salbutamol in Humans
Chest, June 1, 2005; 127(6): 2057 - 2063.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P G Camici
Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction
Heart, April 1, 2005; 91(4): 421 - 422.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Duncker, D. B. Haitsma, D. A. Liem, P. D. Verdouw, and D. Merkus
Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction
Cardiovasc Res, March 1, 2005; 65(4): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al.
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
Eur. Heart J., February 2, 2005; 26(4): 384 - 416.
[Full Text] [PDF]


Home page
J Clin PharmacolHome page
B. F. McBride and C. M. White
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET
J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Nakayama, X. Yan, R. L. Price, T. K. Borg, K. Ito, A. Sanbe, J. Robbins, and B. H. Lorell
Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H317 - H327.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Torre-Amione, F. Sestier, B. Radovancevic, and J. Young
Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: Results of a randomized, controlled, phase II trial
J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1181 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers
Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis
Cardiovasc Res, March 15, 2003; 57(4): 887 - 896.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Spyrou, S. D. Rosen, F. Fath-Ordoubadi, R. Jagathesan, R. Foale, J. S. Kooner, and P. G. Camici
Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1216 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Metra, S. Nodari, A. D'Aloia, C. Muneretto, A. D. Robertson, M. R. Bristow, and L. Dei Cas
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1248 - 1258.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Senzaki, S. Masutani, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, Y. Yokote, and A. Ishizawa
Ventricular Afterload and Ventricular Work in Fontan Circulation: Comparison With Normal Two-Ventricle Circulation and Single-Ventricle Circulation With Blalock-Taussig Shunts
Circulation, June 18, 2002; 105(24): 2885 - 2892.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras
Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure
Eur. Heart J., May 2, 2002; 23(10): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Delforge, D. Mesangeau, F. Dolle, P. Merlet, C. Loc'h, M. Bottlaender, R. Trebossen, and A. Syrota
In Vivo Quantification and Parametric Images of the Cardiac {beta}-Adrenergic Receptor Density
J. Nucl. Med., February 1, 2002; 43(2): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. A Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P Shannon
Catecholamine stimulation is associated with impaired myocardial O2 utilization in heart failure
Cardiovasc Res, February 1, 2002; 53(2): 392 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. S. Houle, R. A. Altschuld, and G. E. Billman
Enhanced in vivo and in vitro contractile responses to {beta}2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias
J Appl Physiol, October 1, 2001; 91(4): 1627 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Burger, M. Benicke, A. Deten, and H.-G. Zimmer
Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H14 - H21.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T.M Ramahi, M.D Longo, A.R Cadariu, K Rohlfs, M Slade, S Carolan, E Vallejo, and F.J.T. Wackers
Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy
Eur. Heart J., May 2, 2001; 22(10): 849 - 856.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers
Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Bristow
Of Phospholamban, Mice, and Humans With Heart Failure
Circulation, February 13, 2001; 103(6): 787 - 788.
[Full Text] [PDF]


Home page
JAMAHome page
R. J. Lefkowitz and J. T. Willerson
Prospects for Cardiovascular Research
JAMA, February 7, 2001; 285(5): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Muro, T Ota, H Watanabe, M Teragaki, K Takeuchi, and J Yoshikawa
Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction
Heart, February 1, 2001; 85(2): 165 - 170.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fässler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al.
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
PNAS, January 23, 2001; (2001) 31444798.
[Abstract] [Full Text]


Home page
HeartHome page
R Schulz and G Heusch
Hibernating myocardium
Heart, December 1, 2000; 84(6): 587 - 594.
[Full Text]


Home page
J Am Coll CardiolHome page
K. Isaaz
What are we actually measuring by Doppler tissue imaging?
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 897 - 899.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. D. Lowes, M. Higginbotham, L. Petrovich, M. A. DeWood, M. A. Greenberg, P. S. Rahko, G. W. Dec, T. H. LeJemtel, R. L. Roden, M. M. Schleman, et al.
Low-dose enoximone improves exercise capacity in chronic heart failure
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D Scrutinio, V Napoli, A Passantino, A Ricci, R Lagioia, and P Rizzon
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome
Eur. Heart J., June 1, 2000; 21(11): 927 - 934.
[Abstract] [PDF]


Home page
HypertensionHome page
W. W. Brooks, O. H. L. Bing, M. O. Boluyt, A. Malhotra, J. P. Morgan, N. Satoh, W. S. Colucci, and C. H. Conrad
Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril
Hypertension, June 1, 2000; 35(6): 1203 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. A. Recchia, R. D. Bernstein, P. B. Sehgal, N. R. Ferreri, and T. H. Hintze
Cytokines Are Not a Requisite Part of the Pathophysiology Leading to Cardiac Decompensation
Experimental Biology and Medicine, January 1, 2000; 223(1): 47 - 52.
[Abstract] [Full Text]


Home page
ChestHome page
F. Sakamaki, T. Satoh, N. Nagaya, S. Kyotani, N. Nakanishi, and Y. Ishida
Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by 123I-Metaiodobenzylguanidine Imaging in Patients With COPD*
Chest, December 1, 1999; 116(6): 1575 - 1581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Billington, I. P. Hall, S. J. Mundell, J.-L. Parent, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn
Inflammatory and Contractile Agents Sensitize Specific Adenylyl Cyclase Isoforms in Human Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 597 - 606.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
S. Sandmann, J.-Y. Min, A. Meissner, and T. Unger
Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca2+-handling in infarct-induced heart failure in rats
Cardiovasc Res, October 1, 1999; 44(1): 67 - 80.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Feldman and C. McTiernan
New Insight Into the Role of Enhanced Adrenergic Receptor-Effector Coupling in the Heart
Circulation, August 10, 1999; 100(6): 579 - 582.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Wattanapermpool and P. J. Reiser
Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H467 - H473.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett
Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice
PNAS, May 25, 1999; 96(11): 6400 - 6405.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. L. Kukin, J. Kalman, R. H. Charney, D. K. Levy, C. Buchholz-Varley, O. N. Ocampo, and C. Eng
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
Circulation, May 25, 1999; 99(20): 2645 - 2651.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. O'Rourke, D. A. Kass, G. F. Tomaselli, S. Kaab, R. Tunin, and E. Marban
Mechanisms of Altered Excitation-Contraction Coupling in Canine Tachycardia-Induced Heart Failure, I : Experimental Studies
Circ. Res., March 19, 1999; 84(5): 562 - 570.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Hartmann, S Ziegler, S Nekolla, M Hadamitzky, M Seyfarth, G Richardt, and M Schwaiger
Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography
Heart, March 1, 1999; 81(3): 262 - 270.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Asai, M. Uechi, N. Sato, W. Shen, T. Meguro, M. A. Mathier, R. P. Shannon, and S. F. Vatner
Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2219 - H2226.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Mardon, P. Merlet, A. Syrota, and B. Maziere
Effects of 5-day hypoxia on cardiac adrenergic neurotransmission in rats
J Appl Physiol, September 1, 1998; 85(3): 890 - 897.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. B. Vroom
Pharmacologic Management of Acute Heart Failure: A Review
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 191 - 203.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
C Mittmann, T Eschenhagen, and H Scholz
Cellular and molecular aspects of contractile dysfunction in heart failure
Cardiovasc Res, August 1, 1998; 39(2): 267 - 275.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. L. Dickstein
Anesthesia for Heart Transplantation
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 131 - 139.
[Abstract] [PDF]


Home page
CirculationHome page
T. Nozawa, A. Igawa, N. Yoshida, M. Maeda, M. Inoue, Y. Yamamura, H. Asanoi, and H. Inoue
Dual-Tracer Assessment of Coupling Between Cardiac Sympathetic Neuronal Function and Downregulation of ß-Receptors During Development of Hypertensive Heart Failure of Rats
Circulation, June 16, 1998; 97(23): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. T. Sullebarger, P. M. D'Ambra, L. C. Clark, L. Thanikarry, and H. L. Fontanet
Effect of Digoxin on Ventricular Remodeling and Responsiveness of {beta}-Adrenoceptors in Chronic Volume Overload
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 281 - 290.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Yamada, T. Ohkura, T. Yamadera, O. Ito, R. Kimura, Y. Nozawa, S. Hayashi, and H. Miyake
Abnormality in Plasma Catecholamines and Myocardial Adrenoceptors in Cardiomyopathic BIO 53.58 Syrian Hamsters and Improvement by Metoprolol Treatment
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1389 - 1395.
[Abstract] [Full Text]


Home page
HeartHome page
M. L Kukin, J. Kalman, M. M Mannino, C. Buchholz-Varley, and O. Ocampo
beta Blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses
Heart, November 1, 1997; 78(5): 444 - 449.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. E. Billman, L. C. Castillo, J. Hensley, C. M. Hohl, and R. A. Altschuld
ß2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation : In Vivo and In Vitro Evidence for Enhanced Sensitivity to ß2-Adrenergic Stimulation in Animals Susceptible to Sudden Death
Circulation, September 16, 1997; 96(6): 1914 - 1922.
[Abstract] [Full Text]


Home page
CirculationHome page
G. S. Bodor, A. E. Oakeley, P. D. Allen, D. L. Crimmins, J. H. Ladenson, and P. A. W. Anderson
Troponin I Phosphorylation in the Normal and Failing Adult Human Heart
Circulation, September 2, 1997; 96(5): 1495 - 1500.
[Abstract] [Full Text]


Home page
CirculationHome page
N. Sato, S. F. Vatner, Y.-T. Shen, R. K. Kudej, B. Ghaleh-Marzban, M. Uechi, K. Asai, I. Mirsky, T. A. Patrick, R. P. Shannon, et al.
Effects of Cardiac Denervation on Development of Heart Failure and Catecholamine Desensitization
Circulation, April 15, 1997; 95(8): 2130 - 2140.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Teramura, T. Yamakado, M. Maeda, and T. Nakano
Effects of MCI-154, a Calcium Sensitizer, on Left Ventricular Systolic and Diastolic Function in Pacing-Induced Heart Failure in the Dog
Circulation, February 4, 1997; 95(3): 732 - 739.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Gorcsan III, S. Murali, P. J. Counihan, W. A. Mandarino, and R. L. Kormos
Right Ventricular Performance and Contractile Reserve in Patients With Severe Heart Failure: Assessment by Pressure-Area Relations and Association With Outcome
Circulation, December 15, 1996; 94(12): 3190 - 3197.
[Abstract] [Full Text]


Home page
CirculationHome page
E. M. Gilbert, W. T. Abraham, S. Olsen, B. Hattler, M. White, P. Mealy, P. Larrabee, and M. R. Bristow
Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart
Circulation, December 1, 1996; 94(11): 2817 - 2825.
[Abstract] [Full Text]


Home page
HypertensionHome page
W. C. De Mello
Impaired Regulation of Cell Communication by ß-Adrenergic Receptor Activation in the Failing Heart
Hypertension, February 1, 1996; 27(2): 265 - 268.
[Abstract] [Full Text]


Home page
CirculationHome page
H. B. Bittner, E. P. Chen, C. A. Milano, S. W.H. Kendall, R. B. Jennings, D. C. Sabiston Jr, and P. Van Trigt
Myocardial ß-Adrenergic Receptor Function and High-Energy Phosphates in Brain Death– Related Cardiac Dysfunction
Circulation, November 1, 1995; 92(9): 472 - 478.
[Abstract] [Full Text]


Home page
Circulation